Assembly Biosciences, Inc. (ASMB)

NASDAQ: ASMB · Real-Time Price · USD

21.12

+0.94 (4.66%)

At close: Nov 13, 2026, 4:00 PM EST

21.28

+0.16 (0.76%)

After-hours: Nov 13, 2026, 7:30 PM EST

Assembly Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	67.01	72.3	28.52	7.16	-	6.25
Revenue Growth	80.18%	153.52%	298.16%	-	-	-92.09%
Cost of Revenue	67.3	64.81	55.93	48.9	69.08	70.15
Gross Profit	-0.29	7.49	-27.41	-41.74	-69.08	-63.9
Selling, General & Admin	21.04	19.61	18.01	22.91	23.93	28.5
Operating Expenses	21.04	19.61	18.01	22.91	23.93	28.5
Operating Income	-21.33	-12.12	-45.42	-64.65	-93.01	-92.4
Interest & Investment Income	10.23	6	5.57	3.45	1.02	0.3
EBT Excluding Unusual Items	-11.1	-6.12	-39.85	-61.2	-91.99	-92.1
Merger & Restructuring Charges	-	-	-	-	-1.1	1.35
Impairment of Goodwill	-	-	-	-	-	-12.6
Asset Writedown	-	-	-	-	-	-0.04
Pretax Income	-11.1	-6.12	-39.85	-61.2	-93.09	-132.39
Income Tax Expense	-	-	0.33	0.03	-	-2.53
Net Income	-11.1	-6.12	-40.18	-61.23	-93.09	-129.86
Net Income to Common	-11.1	-6.12	-40.18	-61.23	-93.09	-129.86
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	19	11	6	5	4	4
Shares Outstanding (Diluted)	19	11	6	5	4	4
Shares Change	116.40%	86.71%	31.18%	13.47%	11.85%	22.17%
EPS (Basic)	-0.60	-0.55	-6.69	-13.38	-23.08	-36.00
EPS (Diluted)	-0.60	-0.55	-6.69	-13.38	-23.08	-36.00
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-40.68	-41.16	-51.15	22.49	-84.57	-96.49
Free Cash Flow Per Share	-2.18	-3.67	-8.52	4.91	-20.96	-26.75
Gross Margin	-0.43%	10.36%	-96.12%	-	-	-
Operating Margin	-31.83%	-16.76%	-159.26%	-902.50%	-	-1477.42%
Profit Margin	-16.57%	-8.47%	-140.87%	-854.78%	-	-2076.35%
Free Cash Flow Margin	-60.70%	-56.93%	-179.33%	313.95%	-	-1542.88%
EBITDA	-21.23	-11.99	-45.29	-64.2	-92.52	-91.93
EBITDA Margin	-31.68%	-16.58%	-158.80%	-	-	-
D&A For EBITDA	0.1	0.13	0.13	0.45	0.5	0.47
EBIT	-21.33	-12.12	-45.42	-64.65	-93.01	-92.4
EBIT Margin	-31.83%	-16.76%	-159.26%	-	-	-

SEC Filings: 10-K · 10-Q